United Therapeutics Corporation (UTHR) vs West Pharmaceutical Services, Inc. (WST)
A side-by-side comparison of United Therapeutics Corporation and West Pharmaceutical Services, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 1, 2026. Differences are shown without an overall score or investment verdict.
UTHR
United Therapeutics Corporation
$573.62HealthcareDelayed quote: Oct 1, 2026, 3:55 PM EDT
WST
West Pharmaceutical Services, Inc.
$364.08HealthcareDelayed quote: Oct 1, 2026, 3:54 PM EDT
Total return — UTHR vs WST
growth of $100 · dividends reinvested · last 10yUTHR +346.1% (+16.1%/yr)WST +414.4% (+17.8%/yr)WST compounded faster over this window
UTHR WST
UTHR vs WST: by the numbers
- •WST is the larger company ($25.62B vs $24.35B market cap).
- •UTHR trades at the lower trailing earnings multiple (20.55 vs 46.56 P/E), one valuation lens rather than an overall verdict.
- •UTHR converts more revenue to profit (41.56% vs 16.98% net margin).
- •UTHR grew revenue faster over the past five years (14.68% vs 5.68% CAGR).
- •WST pays a dividend (0.24% yield), while UTHR has no payments in the available dividend history.
Metrics side by side
Valuation
| Metric | UTHR | WST |
|---|---|---|
| P/E ratio | 20.55 | 46.56 |
| Forward P/E | 21.97 | 40.59 |
| P/S ratio | 7.72 | 7.70 |
| P/B ratio | 3.80 | 8.57 |
| EV / EBITDA | 15.08 | 29.42 |
| FCF yield | 4.49% | 1.71% |
Profitability
| Metric | UTHR | WST |
|---|---|---|
| Gross margin | 86.14% | 36.77% |
| Operating margin | 44.49% | 20.64% |
| Net margin | 41.56% | 16.98% |
| ROE | 20.48% | 18.89% |
| ROIC | 17.69% | 15.77% |
Dividends
| Metric | UTHR | WST |
|---|---|---|
| Dividend yield | N/A | 0.24% |
| Payout ratio | N/A | 11.25% |
Growth (annualized)
| Metric | UTHR | WST |
|---|---|---|
| Revenue CAGR (5Y) | 14.68% | 5.68% |
| EPS CAGR (5Y) | 20.93% | 7.85% |
| FCF CAGR (5Y) | 14.31% | 8.74% |
| Total return CAGR (5Y) | 24.04% | -2.42% |
Frequently asked
- Which has the lower trailing P/E, UTHR or WST?
- UTHR has the lower trailing P/E: UTHR trades at 20.55 and WST at 46.56. P/E is one valuation measure and does not by itself establish which business is cheaper.
- Which has grown faster, UTHR or WST?
- Over the past five years, UTHR grew revenue faster — UTHR at a 14.68% CAGR versus WST at 5.68%.
- Does UTHR or WST pay a bigger dividend?
- WST pays a dividend (0.24% yield), while UTHR has no payments in the available dividend history.
- Is UTHR or WST more profitable?
- UTHR runs the higher net margin — UTHR at 41.56% versus WST at 16.98%.
- How have UTHR and WST total returns compared?
- Over the past 10 years, UTHR delivered 16.46% and WST delivered 17.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
United Therapeutics P/E ratioWest Pharmaceutical Services P/E ratioWest Pharmaceutical Services dividend yieldUnited Therapeutics ROEWest Pharmaceutical Services ROEUnited Therapeutics operating marginWest Pharmaceutical Services operating marginUnited Therapeutics revenue growthWest Pharmaceutical Services revenue growthUnited Therapeutics free cash flowWest Pharmaceutical Services free cash flow
United Therapeutics & West Pharmaceutical Services appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 1, 2026.